Craft

Olink

Stock Price

$26.1

2024-07-15

Market Capitalization

$3.2 B

2024-07-11

Revenue

$169.6 M

FY, 2023

Olink Summary

Company Summary

Overview
Olink Proteomics is a company providing products and services for human protein biomarker discovery. It offers a technique to identify actionable biomarkers that focuses on the human plasma proteome. The company provides cardiometabolic, cell regulation, cardiovascular, immune response, and other panels.
Type
Public
Status
Active
Founded
2004
HQ
Uppsala, SE | view all locations
Website
https://www.olink.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Jon Heimer

    Jon Heimer, Chief Executive Officer

  • Oskar Hjelm

    Oskar Hjelm, Chief Financial Officer

  • Rickard El Tarzi

    Rickard El Tarzi, Chief Strategy Officer

  • Ida Grundberg

    Ida Grundberg, Chief Scientific Officer

Operating MetricsView all

Patents

42

Feb, 2021

Patent Families

10

Feb, 2021

Customers Served

630

Mar, 2021

LocationsView all

5 locations detected

  • Uppsala, Uppsala län HQ

    Sweden

    Uppsala Science Park

  • Watertown, MA

    United States

    65 Grove St

  • Tokyo

    Japan

  • Barcelona, CT

    Spain

  • Uppsala, Uppsala län

    Sweden

    Dag Hammarskjölds Väg 52B

Olink Financials

Summary Financials

Revenue (Q1, 2024)
$28.8M
Gross profit (Q1, 2024)
$24.4M
Net income (Q1, 2024)
($16.1M)
Cash (Q1, 2024)
$109.3M
EBIT (Q1, 2024)
($24.9M)
Enterprise value
($83.1M)

Footer menu